SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001683168-23-005040
Filing Date
2023-07-21
Accepted
2023-07-21 17:00:05
Documents
1
Period of Report
2023-07-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2991
  Complete submission text file 0001683168-23-005040.txt   4406
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Issuer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1129 N. MCDOWELL BLVD PETALUMA CA 94954
Business Address
Dal Poggetto John (Reporting) CIK: 0001791040 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33216 | Film No.: 231103056